top of page

WHAT WE DO
Advancing Surgical Planning
with Innovative AR Solutions

Pushing Beyond the Boundaries for Patient Safety

SKIA is dedicated to transforming surgical planning procedures through augmented reality-based solutions.
By reducing
surgical deviation, we aim to create safer surgical environments for patients.

Our Goals

Surgical navigation for all specialties

Surgical navigation has only been available in the neurosurgical field. However, other surgical specialties also need navigational aid to improve surgical outcomes. With groundbreaking synergy between AI and AR, SKIA is dedicated to providing a comprehensive navigational solution for all surgeons.

Revolutionizing surgical navigation

The current setup procedure for surgical navigation systems is highly complicated and difficult to learn. Moreover, the conventional systems are heavy and require a large space. We have condensed our powerful navigation into a mobile device and made it intuitive to use. The fast mobility of our system allows surgical navigation to be used in many of the emergency cases where conventional systems cannot enter.

Empower patients with knowledge

Imagine being diagnosed with a deep-seated brain tumor, a condition that's hard to fully grasp. SKIA transforms this experience by allowing patients to visualize their internal anatomy and understand the surgical approach in detail. By empowering patients with accessible knowledge, we help them make more informed and confident decisions about their health.

  History

We consistently deliver impactful solutions to benefit both patients and surgeons

May

Starting Confirmatory Clinical Trial for SKIA Breast

Feb

Project μ with Mayo Clinic

Jan

Started Clinical Trial for SKIA Head in Korea

Meet Our Team
 

Our team establishes new frontiers and pushes boundaries, driving continuous progress and innovation
to harness the full potential of artificial intelligence and augmented reality.

JONGMYOUNG LEE

Jongmyoung Lee
Chief Executive Officer

HYUK KWON

Hyuk Kwon
Chief Operating Officer

JUNWOO LEE

Dr. Junwoo Lee
Chief Medical Officer

SEUNGWON NA

Seungwon Na
Chief Technical Officer

JEONGJIN LEE

Prof. Jeongjin Lee
AI R&D Leader

ABHISHEK BANDARU

Abhishek Bandaru
COO, SKIA India

DR MANJULA ANAGANI

Dr. Manjula Anagani
Clinical Advisor, SKIA India

Main Investors

A total of 10 million USD has been secured.
Series A-B Bridge Round has recently closed.

Bluepoint Partners

Bluepoint Partners

Golden Oak Investment

Golden Oak Invetment

TS Investment

TS Invetment

Albatross Investment

Albatross Investment

KVIC

KVIC

Aventures

AVentures

Industrial Bank of Korea

Industrial Bank of Korea

SK Securities

SK Securities

Hyundai Pharm

Hyundai Pharm

SKIA LOGO WHITE

Solutions

Company

Contact

EMAIL
LINKEDIN
YOUTUBE

SKIA Head, Breast, and Forensics solutions are under development and not commercially available at this time. 

 

​​SKIA Face and Body are currently approved in South Korea, and SKIA OPD is available for sale. Media shown on this website are actual patient cases, but all personal identities have been removed or otherwise anonymized.

​

SKIA Head and Breast are not yet cleared by the FDA and are not available for sale. Any information about the device, including its potential benefits and risks, is based on preliminary data and should be interpreted accordingly. These devices are not intended for diagnosing, treating, or preventing medical conditions without the supervision of a qualified healthcare professional. SKIA does not guarantee the accuracy or completeness of the information provided and is not liable for any damages arising from the use of the devices or reliance on the information.

©2025 SKIA Inc.

Copyright © 2024 SKIA

bottom of page